NCT02393287 - Retroprospective Real Life Observatory of Eribulin | Biotech Hunter

Enrollment

753

Participants

Timeline

Start Date

November 30, 2014

Primary Completion Date

September 30, 2016

Study Completion Date

January 31, 2017

Conditions

Metastatic Breast Cancer

Interventions

OTHER

Eribulin (ReProLine)

this is an observational trial ; there is no intervention

Trial Locations (13)

Clinique Armoricaine de Radiologie, Saint-Brieuc

CHU Jean Minjoz, Besançon

CHU, Brest

Centre Eugène Marquis, Rennes

CH, St-Malo

Institut de Cancerologie de l'Ouest, Nantes

Institut de Cancerologie de l'Ouest, Angers

Centre Jean Godinot, Reims

Centre Alexis Vautrin, Vandœuvre-lès-Nancy

Centre Paul Strauss, Strasbourg

Centre Léon Berard, Lyon

Centre Jean Bernard, Le Mans

Centre Henri Becquerel, Rouen

All Listed Sponsors

lead

Institut Cancerologie de l'Ouest

OTHER